Home/Filings/4/0001225208-24-008721
4//SEC Filing

Dahl Andrew M. 4

Accession 0001225208-24-008721

CIK 0001099800other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:25 PM ET

Size

5.2 KB

Accession

0001225208-24-008721

Insider Transaction Report

Form 4
Period: 2024-09-13
Dahl Andrew M.
SVP, Corporate Controller
Transactions
  • Award

    Common Stock

    2024-09-13+2,9204,690.783 total
Footnotes (1)
  • [F1]These restricted stock units were granted on September 13, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0002022347

Filing Metadata

Form type
4
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:25 PM ET
Size
5.2 KB